Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature

Mycopathologia. 2013 Feb;175(1-2):129-34. doi: 10.1007/s11046-012-9591-2. Epub 2012 Oct 17.

Abstract

We report on the treatment with micafungin of a pacemaker-associated endocarditis due to Candida albicans. Antifungal therapy was able to reduce vegetation size from 5 to 1 cm making possible the transvenous removal of the device without a high risk of pulmonary embolism. Noteworthy, a high micafungin concentration was documented into the lead vegetation (10 μg/g of vegetation tissue) and this may have contributed to the striking size reduction of vegetation.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antifungal Agents / therapeutic use*
  • Candida albicans / drug effects
  • Candida albicans / isolation & purification*
  • Echinocandins / therapeutic use*
  • Echocardiography
  • Endocarditis / diagnosis*
  • Endocarditis / drug therapy*
  • Endocarditis / microbiology
  • Endocarditis / pathology
  • Female
  • Humans
  • Lipopeptides / therapeutic use*
  • Micafungin
  • Microbial Sensitivity Tests
  • Pacemaker, Artificial / adverse effects*
  • Prostheses and Implants / adverse effects*
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Micafungin